Hong Kong Pharmaceuticals Stock News

As global markets navigate a complex landscape marked by steady interest rates in the U.S., a significant rate hike in Japan, and mixed economic signals across regions, investors are increasingly focused on small-cap stocks that have shown resilience amidst these shifts. In this dynamic environment, identifying undiscovered gems often involves seeking companies with strong fundamentals and growth potential that can thrive despite broader market volatility.

Why Air China’s latest operating update matters for shareholders Air China (SEHK:753) has drawn market attention after releasing detailed operating results for May 2026 and the year to date, covering capacity, traffic, load factors, and both passenger and cargo volumes. These figures give investors a fresh snapshot of how intensively the airline is using its fleet, how full its planes are, and how passenger and cargo trends compare between the single month of May and the broader year to...

ASMPT (SEHK:522) drew investor attention after securing a repeat order for eight Firebird Thermo Compression Bonding tools from a leading integrated device manufacturer. This highlighted the continued use of its equipment in high volume chip production. See our latest analysis for ASMPT. Beyond this repeat order, ASMPT’s recent share price performance has been strong, with a 30 day share price return of 8.78%, a 90 day share price return of 87.31%, and a 1 year total shareholder return of...

AGTech Holdings (SEHK:8279) has drawn fresh attention after reporting full year results to March 31, 2026, with sales of HK$760.52 million and a reduced net loss of HK$39.74 million. See our latest analysis for AGTech Holdings. The latest full year results appear to have kept interest in AGTech Holdings high, with the share price at HK$0.71 and a year-to-date share price return of 249.75%. The 1-year total shareholder return of 243.00% points to strong momentum over a longer stretch, even...

BYD stock performance sets the stage for valuation questions BYD (SEHK:1211) has come under pressure recently, with the stock down about 17% over the past month and about 26% over the past 3 months, prompting fresh scrutiny of its current valuation. Those moves sit against a longer track record that includes a year to date decline of about 23% and a total return decline of about 41% over the past year, even as the company reports sizeable revenue and net income. See our latest analysis for...

We can readily understand why investors are attracted to unprofitable companies. For example, Million Cities Holdings...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Hilong Holding Limited ( HKG:1623 ) insiders who purchased shares in the last 12 months were richly rewarded last week...

In the last year, many Sino Land Company Limited ( HKG:83 ) insiders sold a substantial stake in the company which may...

As Asian markets navigate a landscape marked by geopolitical developments and shifting monetary policies, investors are keenly observing the region's economic resilience and potential growth sectors. Penny stocks, though often seen as remnants of past trading eras, continue to offer intriguing opportunities for those willing to explore smaller or emerging companies with strong financial foundations. In this article, we highlight three Asian penny stocks that exemplify the blend of...

Knowledge Atlas Technology (SEHK:2513) drew fresh attention after Elon Musk publicly discussed China’s AI capabilities, linking them to the company’s progress, with Zhipu AI’s CEO responding that reaching leading global model quality “won't take that long.” See our latest analysis for Knowledge Atlas Technology. Beyond the high profile comments on China’s AI capabilities, Knowledge Atlas Technology’s recent AGM brought a new independent non executive director, a rebrand to Z.AI Co., Ltd., and...

Yankuang Energy Group (SEHK:1171) is back in focus after recent analyst updates highlighted a higher consensus earnings outlook, a Strong Buy rating, and strong momentum and value scores that have drawn fresh investor attention. See our latest analysis for Yankuang Energy Group. At a share price of HK$12.23, Yankuang Energy Group has given investors a 25.44% year to date share price return and a 61.36% total shareholder return over the past year. However, momentum has cooled recently, with...

Safety Godown Company (SEHK:237) has released its H1 2026 numbers, reporting revenue of HK$139.0 million and a net loss of HK$17.6 million, equal to a basic EPS loss of HK$0.04. The trailing 12 month figures show revenue of HK$235.0 million and a net loss of HK$283.3 million, or a basic EPS loss of HK$0.70. Over recent halves, the company has seen revenue move from HK$115.2 million in H1 2025 to HK$96.0 million in H2 2025 and then to HK$139.0 million in H1 2026. EPS shifted from roughly...

Lenovo Group (SEHK:992) recently expanded its Hybrid AI Advantage portfolio, introducing new AI inferencing and agentic AI tools aimed at helping enterprises deploy AI agents more efficiently and at lower operating cost across devices and data centers. See our latest analysis for Lenovo Group. The recent Hybrid AI announcements, new tablet launch and a completed US$2b zero coupon convertible bond sit against a backdrop of strong momentum, with a 30-day share price return of 45.52% and a...

Ascletis Pharma (SEHK:1672) has attracted investor attention after receiving U.S. FDA Investigational New Drug clearance for ASC35, a once-monthly dual GLP-1/GIP agonist that is being advanced into a Phase I obesity trial. See our latest analysis for Ascletis Pharma. The FDA IND clearance arrives after a volatile year for Ascletis Pharma, with the share price down 35.2% over the past month and 37.9% over three months, while still delivering a 3-year total shareholder return of 418.5% and a...

Palasino Holdings (SEHK:2536) has reported its FY 2026 first half results with revenue of HK$305.2 million and basic EPS of HK$0.014, setting the tone for a period where profitability and scale are firmly in focus. Over the last three reported halves, the company has seen revenue move from HK$282.1 million in FY 2025 H1 to HK$286.1 million in FY 2025 H2 and now HK$305.2 million in FY 2026 H1. Basic EPS shifted from HK$0.019 in FY 2025 H1 to a slight loss in FY 2025 H2 before landing at...

Jacobson Pharma (SEHK:2633) has reported first half FY 2026 revenue of HK$766.6 million and basic EPS of HK$0.071, with trailing twelve month revenue at HK$1.6 billion and EPS at HK$0.151, giving investors a clear view of its recent earnings power. The company has seen half yearly revenue move from HK$810.0 million and EPS of HK$0.071 in the first half of FY 2025 to HK$766.9 million and EPS of HK$0.081 in the second half of FY 2025. This sets the stage for the latest numbers to be read...

Lotus Horizon Holdings (SEHK:6063) has opened FY 2026 with first half revenue of HK$120.0 million and basic EPS of HK$0.000647, against a trailing 12 month picture where revenue was HK$226.0 million and the company reported a net loss of HK$3.3 million and EPS of HK$0.0017. Over the past three reported half year periods, revenue has moved from HK$130.7 million with EPS of HK$0.001009 in 1H FY 2025 to HK$129.2 million with EPS of HK$0.000587 in 2H FY 2025, and then to HK$120.0 million with EPS...

Global markets have been influenced by key developments, such as the Federal Reserve's decision to hold interest rates steady and the Bank of Japan's rate hike to a 31-year high. Against this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for investors seeking growth potential at lower price points. While the term "penny stocks" may seem outdated, these investments can still present valuable prospects when they exhibit strong...

As global markets navigate a complex landscape of monetary policy shifts and geopolitical developments, Asian equities have shown resilience amid mixed economic signals. With Japan's stock markets surging to new heights and China grappling with uneven recovery, investors are keenly observing opportunities for undervalued stocks that might offer significant upside potential. Identifying stocks trading below their intrinsic value can be particularly appealing in such uncertain times, as these...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Viewing insider transactions for Vala Inc.'s ( HKG:2051 ) over the last year, we see that insiders were net buyers...

Insiders who bought CN¥6.69m worth of Xiabuxiabu Catering Management (China) Holdings Co., Ltd.'s ( HKG:520 ) stock at...